Qc Counselor Plc | |
2028 E 38th St Ste 3 Davenport IA 52807-1168 | |
(563) 424-2016 | |
(563) 424-2017 |
Full Name | Qc Counselor Plc |
---|---|
Speciality | Counselor |
Location | 2028 E 38th St Ste 3, Davenport, Iowa |
Authorized Official Name and Position | Matthew John Martenson (OWNER) |
Authorized Official Contact | 5634242016 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Qc Counselor Plc 2028 E 38th St Suite 3 Davenport IA 52807-1168 Ph: (563) 424-2016 | Qc Counselor Plc 2028 E 38th St Ste 3 Davenport IA 52807-1168 Ph: (563) 424-2016 |
NPI Number | 1285919977 |
---|---|
Provider Enumeration Date | 10/13/2011 |
Last Update Date | 12/28/2023 |
Certification Date | 12/28/2023 |
Medicare PECOS PAC ID | 9537510730 |
---|---|
Medicare Enrollment ID | O20240112000654 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1285919977 | NPI | - | NPPES |
11087500000 | Medicaid | IA | |
1285919977 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 00728 (Iowa) | Primary |
Provider Name | Matthew John Martenson |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1275088114 PECOS PAC ID: 0446601645 Enrollment ID: I20240112001104 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
› Verified 5 days ago
Provider Name | Mollie Ann Schmelzer |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1700138120 PECOS PAC ID: 8426400664 Enrollment ID: I20240123003977 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
› Verified 5 days ago
News Archive
Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.
Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
› Verified 5 days ago
Courageous Aim Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2805 Eastern Ave Ste D, Davenport, IA 52803 Phone: 563-505-0141 | |
Vera French Community Mental Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1441 W Central Park Ave, Davenport, IA 52804 Phone: 563-383-1900 Fax: 563-328-5690 | |
Hope For Tomorrow Therapy Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1140 E Kimberly Rd Ste 110, Davenport, IA 52807 Phone: 563-200-3154 Fax: 833-228-5356 | |
Ciaccio Medical, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1401 W Central Park Ave, Davenport, IA 52804 Phone: 309-236-8075 | |
The Robert Young Center For Community Mental Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12160 S Utah Ave, Davenport, IA 52804 Phone: 563-326-1150 | |
Revolution Counseling Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 601 Brady St Ste 204, Davenport, IA 52803 Phone: 309-781-4053 Fax: 309-792-2440 | |
Bhg Lxxxvi, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3811 North Harrison Street, Obot Room #100, Davenport, IA 52806 Phone: 563-388-8000 Fax: 563-388-8002 |